Endocrine Disruption Assessments

This webinar will provide a general overview of endocrine disruption, regulations for EDCs in the European Union (EU), methodology for identification of EDCs as per the ECHA/EFSA guidance, and the new REACH requirements  and CLP classification criteria for EDCs in the EU.

There is a growing interest in identifying and assessing the safety of endocrine disrupting chemicals (EDCs) in consumer products by industry and regulators alike. The identification of EDCs employs a thorough investigation of the endocrine potential of the chemical from evaluating datasets from various tests spanning across in vitro, in vivo and in silico models.  The overall judgement of ED potential considers the weight-of-evidence of the data gathered and is reported systematically to enable an expert judgement. The identification and assessment of EDCs is complimented by guidances from the EFSA/ECHA and the OECD. 

Intertek can assist clients with conducting comprehensive literature searches to enable identification of EDCs, weight-of-evidence evaluation and expert judgement of ED potential, and compilation of REACH registration dossiers to comply with regulatory requirements for EDCs in the European Union. 

07 November 2024 | 10am EST, 3pm GMT, 4pm CET

By completing this form, you submit your information to the webinar organizer, who will use it to communicate with you regarding this event and their other services.